ARDENT HEALTH INC (ARDT) Stock Fundamental Analysis
NYSE:ARDT - New York Stock Exchange, Inc. - US03980N1072 - Common Stock - Currency: USD
Overall ARDT gets a fundamental rating of 5 out of 10. We evaluated ARDT against 102 industry peers in the Health Care Providers & Services industry. ARDT has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on ARDT.
1. Profitability
1.1 Basic Checks
ARDT had positive earnings in the past year.
ARDT had a positive operating cash flow in the past year.
1.2 Ratios
ARDT has a Return On Assets of 4.57%. This is in the better half of the industry: ARDT outperforms 76.47% of its industry peers.
The Return On Equity of ARDT (19.12%) is better than 86.27% of its industry peers.
With a decent Return On Invested Capital value of 8.15%, ARDT is doing good in the industry, outperforming 75.49% of the companies in the same industry.
ARDT had an Average Return On Invested Capital over the past 3 years of 5.96%. This is below the industry average of 9.62%.
The last Return On Invested Capital (8.15%) for ARDT is above the 3 year average (5.96%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.57% | ||
| ROE | 19.12% | ||
| ROIC | 8.15% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
1.3 Margins
ARDT has a Profit Margin of 3.73%. This is in the better half of the industry: ARDT outperforms 70.59% of its industry peers.
In the last couple of years the Profit Margin of ARDT has grown nicely.
ARDT has a Operating Margin of 6.59%. This is in the better half of the industry: ARDT outperforms 68.63% of its industry peers.
ARDT's Operating Margin has improved in the last couple of years.
ARDT has a better Gross Margin (57.32%) than 80.39% of its industry peers.
ARDT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.59% | ||
| PM (TTM) | 3.73% | ||
| GM | 57.32% |
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ARDT is creating some value.
Compared to 1 year ago, ARDT has more shares outstanding
The debt/assets ratio for ARDT has been reduced compared to a year ago.
2.2 Solvency
ARDT has an Altman-Z score of 2.14. This is not the best score and indicates that ARDT is in the grey zone with still only limited risk for bankruptcy at the moment.
ARDT has a Altman-Z score (2.14) which is in line with its industry peers.
The Debt to FCF ratio of ARDT is 9.36, which is on the high side as it means it would take ARDT, 9.36 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.36, ARDT is in line with its industry, outperforming 49.02% of the companies in the same industry.
A Debt/Equity ratio of 0.93 indicates that ARDT is somewhat dependend on debt financing.
ARDT has a Debt to Equity ratio of 0.93. This is in the lower half of the industry: ARDT underperforms 61.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | 9.36 | ||
| Altman-Z | 2.14 |
ROIC/WACC1.03
WACC7.89%
2.3 Liquidity
A Current Ratio of 2.12 indicates that ARDT has no problem at all paying its short term obligations.
ARDT's Current ratio of 2.12 is fine compared to the rest of the industry. ARDT outperforms 76.47% of its industry peers.
ARDT has a Quick Ratio of 1.98. This is a normal value and indicates that ARDT is financially healthy and should not expect problems in meeting its short term obligations.
ARDT's Quick ratio of 1.98 is fine compared to the rest of the industry. ARDT outperforms 76.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.98 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 314.38% over the past year.
Measured over the past years, ARDT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.75% on average per year.
The Revenue has grown by 10.29% in the past year. This is quite good.
Measured over the past years, ARDT shows a small growth in Revenue. The Revenue has been growing by 7.00% on average per year.
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%53.26%
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%4.04%
3.2 Future
Based on estimates for the next years, ARDT will show a very strong growth in Earnings Per Share. The EPS will grow by 21.97% on average per year.
ARDT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.43% yearly.
EPS Next Y58.43%
EPS Next 2Y28.98%
EPS Next 3Y21.97%
EPS Next 5YN/A
Revenue Next Year8.29%
Revenue Next 2Y6.9%
Revenue Next 3Y6.43%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ARDT is valuated reasonably with a Price/Earnings ratio of 8.33.
95.10% of the companies in the same industry are more expensive than ARDT, based on the Price/Earnings ratio.
ARDT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.55.
With a Price/Forward Earnings ratio of 6.56, the valuation of ARDT can be described as very cheap.
Based on the Price/Forward Earnings ratio, ARDT is valued cheaply inside the industry as 95.10% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.40. ARDT is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.33 | ||
| Fwd PE | 6.56 |
4.2 Price Multiples
93.14% of the companies in the same industry are more expensive than ARDT, based on the Enterprise Value to EBITDA ratio.
72.55% of the companies in the same industry are more expensive than ARDT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.21 | ||
| EV/EBITDA | 4.63 |
4.3 Compensation for Growth
ARDT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ARDT may justify a higher PE ratio.
A more expensive valuation may be justified as ARDT's earnings are expected to grow with 21.97% in the coming years.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y28.98%
EPS Next 3Y21.97%
5. Dividend
5.1 Amount
ARDT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:ARDT (6/12/2025, 11:06:05 AM)
13.41
+0.07 (+0.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners72.28%
Inst Owner Change1.21%
Ins Owners1.82%
Ins Owner Change1.41%
Market Cap1.92B
Analysts81.25
Price Target20.57 (53.39%)
Short Float %1.5%
Short Ratio4.33
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)59.62%
Min EPS beat(2)43.05%
Max EPS beat(2)76.2%
EPS beat(4)3
Avg EPS beat(4)21.25%
Min EPS beat(4)-44.28%
Max EPS beat(4)76.2%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.04%
Min Revenue beat(2)-2.01%
Max Revenue beat(2)6.1%
Revenue beat(4)1
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)6.1%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.28%
PT rev (3m)-6.64%
EPS NQ rev (1m)-5.18%
EPS NQ rev (3m)49.83%
EPS NY rev (1m)0.92%
EPS NY rev (3m)-1.36%
Revenue NQ rev (1m)-0.67%
Revenue NQ rev (3m)4.83%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.19%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.33 | ||
| Fwd PE | 6.56 | ||
| P/S | 0.32 | ||
| P/FCF | 16.21 | ||
| P/OCF | 6.29 | ||
| P/B | 1.63 | ||
| P/tB | 8.65 | ||
| EV/EBITDA | 4.63 |
EPS(TTM)1.61
EY12.01%
EPS(NY)2.05
Fwd EY15.25%
FCF(TTM)0.83
FCFY6.17%
OCF(TTM)2.13
OCFY15.9%
SpS42.12
BVpS8.22
TBVpS1.55
PEG (NY)0.14
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.57% | ||
| ROE | 19.12% | ||
| ROCE | 9.73% | ||
| ROIC | 8.15% | ||
| ROICexc | 9.28% | ||
| ROICexgc | 12.64% | ||
| OM | 6.59% | ||
| PM (TTM) | 3.73% | ||
| GM | 57.32% | ||
| FCFM | 1.96% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
ROICexc(3y)6.85%
ROICexc(5y)N/A
ROICexgc(3y)9.47%
ROICexgc(5y)N/A
ROCE(3y)7.12%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
F-Score8
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | 9.36 | ||
| Debt/EBITDA | 2 | ||
| Cap/Depr | 126.81% | ||
| Cap/Sales | 3.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.04% | ||
| Profit Quality | 52.68% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.98 | ||
| Altman-Z | 2.14 |
F-Score8
WACC7.89%
ROIC/WACC1.03
Cap/Depr(3y)111.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%53.26%
EPS Next Y58.43%
EPS Next 2Y28.98%
EPS Next 3Y21.97%
EPS Next 5YN/A
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%4.04%
Revenue Next Year8.29%
Revenue Next 2Y6.9%
Revenue Next 3Y6.43%
Revenue Next 5YN/A
EBIT growth 1Y87.99%
EBIT growth 3Y10.2%
EBIT growth 5YN/A
EBIT Next Year71.17%
EBIT Next 3Y25.43%
EBIT Next 5YN/A
FCF growth 1Y51.28%
FCF growth 3Y152.66%
FCF growth 5YN/A
OCF growth 1Y42.1%
OCF growth 3Y28.95%
OCF growth 5YN/A